Business
The ASX health giant riding COVID’s second wave – The Australian Financial Review
Fisher & Paykel Healthcare’s humidifiers have become vital to the treatment of COVID-19 cases. But investors are starting to look beyond the virus.
Operating revenue surged 59 per cent to $NZ910.2 million ($862.7 million) as earnings rose 86 per cent to $NZ225.5 million ($213.7 million).
Typically, the group has derived about 60 per cent of its revenue from selling hardware and associated consumables into hospitals, with the other 40 per cent from selling products for home care, particularly in the treatment of sleep apnoea.
But in the September half, 75 per cent of revenue came from the hospital side of the business. Hospital hardware sales…
-
General17 hours agoAlleged Croydon Park gunman Artemios Mintzas charged with 25 offences
-
General23 hours agoTeam Australia wins back-to-back Motocross of Nations titles
-
Noosa News24 hours agoYork family honours late son with tractor museum to fund cancer research
-
Noosa News19 hours agoPerth Royal Show attendance slumps to 10-year low